Your browser doesn't support javascript.
loading
Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial.
Ahmadi, Majid; Abdolmohamadi-Vahid, Samaneh; Ghaebi, Mahnaz; Dolati, Sanam; Abbaspour-Aghdam, Sanaz; Danaii, Shahla; Berjis, Katayoun; Madadi-Javid, Rahime; Nouri, Zahra; Siahmansouri, Homayoon; Babaloo, Zohreh; Nouri, Mohammad; Yousefi, Mehdi.
Afiliación
  • Ahmadi M; Immunology Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Student's Research Committee, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Abdolmohamadi-Vahid S; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ghaebi M; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Dolati S; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Abbaspour-Aghdam S; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Danaii S; Gynecology Department, Eastern Azerbaijan ACECR ART Centre, Eastern Azerbaijan branch of ACECR, Tabriz, Iran.
  • Berjis K; Academic Centre for Education, Culture and Research, ACECR, Qom Branch, Qom, Iran.
  • Madadi-Javid R; Gynecology Department, Eastern Azerbaijan ACECR ART Centre, Eastern Azerbaijan branch of ACECR, Tabriz, Iran.
  • Nouri Z; Academic Centre for Education, Culture and Research, ACECR, Qom Branch, Qom, Iran.
  • Siahmansouri H; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Babaloo Z; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nouri M; Stem Cell and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Yousefi M; Stem Cell Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Yousefime@tbzmed.ac.ir.
Int Immunopharmacol ; 74: 105730, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31299610
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aborto Habitual / Linfocitos T Reguladores / Sirolimus / Células Th17 / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aborto Habitual / Linfocitos T Reguladores / Sirolimus / Células Th17 / Inmunosupresores Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Irán